General Information of Drug (ID: DMVGN42)

Drug Name
TRX-818 Drug Info
Synonyms
CVM-1118; ZRPWVAHVWBPHID-UHFFFAOYSA-L; TRX-818 sodium; TRX818; EX-A580; MolPort-044-567-575; CVM-1118(CVM1118); B5932; J-690105; (2'S,3R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluorophenyl)-N-((1r,4R)-4-hydroxycyclohexyl)-2'-neopentyl-2-oxospiro[indoline-3,3'-pyrroli dine]-5'-carboxamide
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
124080980
TTD Drug ID
DMVGN42

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Angiogenesis (AGG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ABI-011 DM1KD7U Lymphoma 2A80-2A86 Phase 1 [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Angiogenesis (AGG) TTB8Y9K NOUNIPROTAC Inhibitor [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)